← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Cerevel Therapeutics, Llc
Cambridge, MA
$10,800,000
Total funding
2
Grants
Funding over time
peak $5.4M · FY2021–24$10M$7.5M$5M$2.5M$0
'21
'22
'23
'24
Funding mix
By agency
NIH$10,800,000 · 2
By mechanism
UG3$5,400,000 · 1
UH3$5,400,000 · 1
Investigators at Cerevel Therapeutics, Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
CVL-354, a kappa opioid receptor antagonist for treatment of opioid use disorder, withdrawal and relapse$5,400,000
UG3 · FY2021 · DA
CVL-354, a kappa opioid receptor antagonist for treatment of opioid use disorder, withdrawal and relapse$2,700,000
UH3 · FY2023 · DA
CVL-354, a kappa opioid receptor antagonist for treatment of opioid use disorder, withdrawal and relapse$2,700,000
UH3 · FY2024 · DA